Related Experiment Video
Updated: Mar 31, 2026

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
[Clinical guidelines for bone disease in primary biliary cirrhosis]
Hiromi Ishibashi1, Atsumasa Komori2
1International University of Health and Welfare/Fukuoka Sanno Hospital, Japan.
Primary biliary cirrhosis (PBC) is a chronic liver disease often linked with osteoporosis. Guidelines recommend calcium, vitamin D, weight-bearing exercise, and medications like alendronate to manage bone health in PBC patients.
Area of Science:
- Hepatology
- Endocrinology
- Bone Metabolism
Context:
- Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease with a high comorbidity of osteoporosis.
- Existing clinical guidelines from Japan, America (AASLD), and Europe (EASL) address the management of bone health in PBC.
- Osteoporosis is a significant concern in patients with chronic liver conditions.
Purpose:
- To review and synthesize current international guidelines for managing osteoporosis in patients with Primary Biliary Cirrhosis.
- To highlight the consensus recommendations for bone health management in PBC.
Summary:
- Guidelines consistently recommend adequate daily calcium intake (1,000-1,200 mg) combined with vitamin D supplementation.
- Weight-bearing exercises are advised as a foundational element of osteoporosis prevention and management.
- Pharmacological interventions, including bisphosphonates such as alendronate, are recommended when lifestyle modifications are insufficient.
Impact:
- Provides a consolidated overview of evidence-based strategies for preventing and treating osteoporosis in PBC.
- Aims to improve clinical practice by standardizing recommendations for bone health in this patient population.
- Facilitates better patient outcomes by addressing a common and serious complication of PBC.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
